Aspen Pharmacare Holdings Limited (LDZA.F)

10.40 +0.10 (+0.97%) At close: 08:03AM CEST

Aspen Pharmacare Holdings Limited

Aspen Place
9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge
Durban
South Africa
27 31 580 8600
https://www.aspenpharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 8,612

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Stephen Bradley Saad BCom, CA(SA)	Group CEO & Executive Director	938.65k	N/A	1964
Mr. Sean M. Capazorio	Group CFO & Executive Director	510.76k	N/A	1967
Ms. Lorraine Hill	Group Chief Operations Officer & Responsible Pharmacist	550.44k	N/A	1964
Mr. Michael Guy Attridge B.Com., CA(SA)	Group Chief Advisor	414.09k	N/A	1961
Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA	Group Chief Corporate Services Officer & Executive Director	385.3k	N/A	1975
Ms. Zizipho Mmango	Group Chief Strategic Development Officer	385.25k	N/A	1985
Sibongakonke Nkosi	Investor Relations Manager	N/A	N/A	N/A
Mr. Trevor Julian Ziman	Regional Chief Executive Officer of Asia Pacific	N/A	N/A	1972
Mr. Samer Kassem	Chief Executive Officer of Aspen Global Incorporated	N/A	N/A	1975
Ms. Raeesa Khan	Group Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

Corporate governance

Aspen Pharmacare Holdings Limited’s ISS governance QualityScore as of 1 April 2024 is 5. The pillar scores are Audit: 7; Board: 4; Shareholder rights: 2; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.